On the basis of an assessment of the available information and the need to review the conclusions of the initial evaluation of the application for approval or, as appropriate, the previous renewal, the F1... competent authority shall, within 90 days of F2receiving an application in accordance with Article F313, decide whether, in the light of current scientific knowledge, a full evaluation of the application for renewal is necessary taking account of all product-types for which renewal is requested.

Where the F4... competent authority decides that a full evaluation of the application is necessary, the evaluation shall be carried out in accordance with paragraphs 1, 2 and 3 of Article 8.

Where the F4... competent authority decides that a full evaluation of the application is not necessary, it shall, within 180 days of F5receiving the application in accordance with Article F613, prepare and submit to the F7Secretary of State and the Devolved Authorities a recommendation on the renewal of the approval of the active substance. It shall provide the applicant with a copy of its recommendation.

The F4... competent authority shall, as soon as possible after F8it has received an application, notify the applicant of the F9appropriate fees. The F4... competent authority shall reject the application if the applicant fails to pay the fees within 30 days of the notification and shall inform the applicant accordingly.

Within 270 days of F10the completion of the evaluation conclusions, if it has carried out a full evaluation of the application, or 90 days otherwise, the F11competent authority shall prepare and submit to the F12Secretary of State and the Devolved Authorities an opinion on renewal of the approval of the active substance.

The competent authority shall update the GB List with details of the renewal of the approval of the active substance

Where, for reasons beyond the control of the applicant, the approval of the active substance is likely to expire before a decision has been taken on its renewal, the Secretary of State shall issue a decision postponing the expiry date of approval for a period sufficient to enable the competent authority to examine the application.

A decision issued under paragraph 4 or 5 above is subject to the consent requirement.

Where the F22Secretary of State decides not to renew or decides to amend the approval of an active substance for one or more product-types, the F23competent authority shall cancel or, where appropriate, amend the authorisations of biocidal products of the product-type(s) concerned containing that active substance. Articles 48 and 52 shall apply accordingly.